Morgans upgrades Pro Medicus Limited (PMCUF) to a Buy
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 25 2025
0mins
Should l Buy ?
Source: Business Insider
Analyst Upgrade: Morgans analyst Iain Wilkie upgraded Pro Medicus Limited (PMCUF) to a Buy with a price target of A$250.00, while the current consensus is a Hold with an average target of $175.01.
Insider Activity: Positive corporate insider sentiment has been observed, with an increase in share purchases by insiders over the past quarter, indicating confidence in the stock's performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
